F065-0127 Screening compound: methyl 1-methyl-4-[(2-{[3-(methylsulfanyl)phenyl]carbamoyl}pyrrolidin-1-yl)sulfonyl]-1H-pyrrole-2-carboxylate

F065-0127 Screening compound: methyl 1-methyl-4-[(2-{[3-(methylsulfanyl)phenyl]carbamoyl}pyrrolidin-1-yl)sulfonyl]-1H-pyrrole-2-carboxylate
F065-0127 Screening compound: methyl 1-methyl-4-[(2-{[3-(methylsulfanyl)phenyl]carbamoyl}pyrrolidin-1-yl)sulfonyl]-1H-pyrrole-2-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound F065-0127
methyl 1-methyl-4-[(2-{[3-(methylsulfanyl)phenyl]carbamoyl}pyrrolidin-1-yl)sulfonyl]-1H-pyrrole-2-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F065-0127

Molecular Formula

C19H23N3O5S2 (C19 H23 N3 O5 S2)

Compound Name

methyl 1-methyl-4-[(2-{[3-(methylsulfanyl)phenyl]carbamoyl}pyrrolidin-1-yl)sulfonyl]-1H-pyrrole-2-carboxylate

IUPAC name

methyl 1-methyl-4-[(2-{[3-(methylsulfanyl)phenyl]carbamoyl}pyrrolidin-1-yl)sulfonyl]-1H-pyrrole-2-carboxylate

SMILES

Cn1c(C(OC)=O)cc(S(N(CCC2)C2C(Nc2cc(SC)ccc2)=O)(=O)=O)c1

InChI

InChI=1S/C19H23N3O5S2/c1-21-12-15(11-17(21)19(24)27-2)29(25,26)22-9-5-8-16(22)18(23)20-13-6-4-7-14(10-13)28-3/h4,6-7,10-12,16H,5,8-9H2,1-3H3,(H,20,23)/t16-/m0/s1

InChI Key

RUOTXTGPJJSILN-INIZCTEOSA-N

MDL Number (MFCD)

MFCD27098182

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

437.54

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.694

Distribution Coefficient, logD

1.694

Water Solubility, LogSw

-2.50

Polar Surface Area

79.361

Acid Dissociation Constant (pKa)

11.19

Base Dissociation Constant (pKb)

-1.30

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

36.80

F065-0127 in Drug Discovery

Included in Screening Libraries

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

KRAS-Targeted Library (16000 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with F065-0127 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F065-0127?
Check Price and Availability of F065-0127, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F065-0127 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F065-0127
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F065-0127
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F065-0127 available by request